Discovery research and clinical trials at the Simmons Cancer Institute at SIU provides the novel findings in cancer biology which will translate to better detection, treatment, and prevention options in the future. Research efforts are revealing fresh aspects in cellular and molecular mechanisms promoting tumor growth and metastases, new biomarkers for earlier detection and monitoring of therapeutic interventions, innovative agents and approaches for the treatment and prevention of cancer growth and proliferation. Simmons Cancer Institute research members performing these discovery-based efforts include:

  • molecular oncology
  • gynecologic oncology
  • immuno-oncology
  • inflammation and oncology
  • urologic oncology
  • cancer biology
  • tumor suppressors
  • ovarian cancer
  • cancer disparities
  • clinical oncology research
  • cell signaling in cancer
  • breast cancer
  • melanoma prevention
  • immunology of cancer
  • cell biology of cancer
  • epidemiology

Simmons Cancer Institute research members also participate in NCI (National Cancer Institute), NIH (National Institutes of Health) and community based research collaborations.